Back to Vet Dispatch

Fish

Velvet Disease in Ornamental Fish: Piscinoodinium, Amyloodinium, Diagnosis, and Control

Aug 21, 2026 7 min read

Bottom line

Velvet disease is a clinical label for external dinoflagellate infestation: Piscinoodinium in freshwater fish and Amyloodinium in saltwater fish.[1] A. ocellatum also affects brackish-water fish.[2] Respiratory distress may precede or occur without a visible gold-dust coating, so examine fresh gill and skin material rather than ruling disease in or out by color alone.[1] Treat the population and system only after confirming the likely organism, defining host and water constraints, and assessing competing causes of gill disease.

From reading to clinical reasoning

Pressure-test the decisions behind this article

Open Clinical Desk with the public topic prefilled. Add patient context only after you are inside the secure vet workspace.

ornamental fish velvet disease

Patient details stay inside the authenticated workspace.

Two syndromes under one name

Merck identifies Piscinoodinium as the freshwater external dinoflagellate and Amyloodinium as the saltwater counterpart; both involve gills and skin.[1] This distinction should remain explicit in the record because evidence and control details are not automatically interchangeable across salinity, species, or production setting.

Amyloodinium ocellatum is an obligate ectoparasitic dinoflagellate of marine and brackish fish. Its trophont attaches to epithelium, then detaches and becomes a reproductive tomont that releases infective dinospores.[2] That off-host component makes the system part of the case even when only one fish initially appears affected.

Freshwater Piscinoodinium is less extensively characterized. A published outbreak in captive-bred F1 Arulius barbs documented trophonts in skin and gills and identified the parasite molecularly.[4] That report establishes disease in that species and cohort; it does not estimate prevalence or predict mortality in other ornamental fish. Merck notes frequent occurrence in zebrafish and some barbs while also stating that any freshwater fish can be affected.[1]

Presentation and initial stabilization

Prioritize respiration. Increased opercular effort, piping, congregation near high-flow or high-oxygen areas, lethargy, reduced appetite, flashing, excess mucus, and sudden mortality can occur. The classic brownish-gold or velvet appearance may be subtle, and Merck notes that small golden spots are not grossly visible when infestation is confined to the gills.[1]

Stabilize dissolved oxygen and minimize handling while obtaining water-quality data. Record temperature, salinity or conductivity, pH, dissolved oxygen, total ammonia nitrogen, nitrite, nitrate, alkalinity, recent transfers, new livestock, shared equipment, filtration changes, treatments, and the temporal pattern of morbidity and mortality. Correct an immediately dangerous environmental abnormality carefully, but do not let an abnormal water result end the infectious workup when the clinical pattern suggests concurrent disease.

Map signs by tank, life-support loop, species, source, and arrival date. A single recirculating system is one epidemiologic unit even when fish occupy separate display compartments. Isolate affected cohorts when the receiving system is mature and compatible, dedicate wet equipment, and prevent movement of water between exposed and unexposed systems.

Diagnostic workflow

Start with direct observation and a complete aquatic history, then perform a physical and dermatologic examination, full water-quality assessment, skin scraping, and gill biopsy. Palmeiro and Roberts identify those elements as the core diagnostic approach to fish dermatologic disease.[3] Sample more than one clinically affected fish when feasible because parasite burden and tissue distribution may differ.

Examine fresh skin mucus, fin, and gill preparations promptly. Merck lists wet mount as the diagnostic method for both freshwater and marine external dinoflagellates.[1] For suspected Amyloodinium, prepare the wet mount in seawater—or water of similar salinity for an estuarine fish—because exposure to freshwater may cause the parasite to detach from tissue.[2]

On wet mount, interpret organism morphology with host, salinity, and tissue site. Amyloodinium trophonts are attached, pigmented, and nonmotile rather than large motile ciliates.[2] Evaluate gills even when the skin looks normal. Conversely, pigment or a dusty sheen without compatible organisms is not diagnostic. Preserve additional tissues for histopathology when branchitis severity, mixed disease, unexplained mortality, or a nondiagnostic wet mount warrants escalation.

PCR can complement microscopy in selected marine or brackish cases, particularly surveillance or suspected low-burden infection. Levy and colleagues developed a specific A. ocellatum ribosomal-DNA assay that detected trophont, tomont, and dinospore stages in seawater and worked in gill tissue.[5] Its analytical performance does not make every negative clinical sample a rule-out; interpret the result alongside sample type, timing, handling, assay validation, and microscopic findings. The assay is for A. ocellatum, not a generic molecular confirmation of freshwater Piscinoodinium.

Differential diagnosis

Do not use “velvet” as a visual diagnosis. White spots, excess mucus, flashing, respiratory effort, pallor, skin haze, and gill injury overlap across infectious and environmental disease.

For discrete white nodules or suspected ciliates, compare the organism and life cycle with ornamental fish ichthyophthiriasis. When hooks or a haptor are seen, or when irritation and branchitis occur without dinoflagellate morphology, use the ornamental fish monogenean infestation workflow. Erosive plaques, necrotic gills, or bacterial rods support a separate workup for columnaris disease in ornamental fish. A population-level respiratory event also requires immediate assessment for ornamental fish ammonia toxicity, hypoxia, nitrite, pH disturbance, chlorine or chloramine exposure, temperature failure, and supersaturated gas.

Mixed disease is plausible. Obtain samples before empiric baths when the patient can tolerate the delay, because prior chemicals, anesthesia, freshwater exposure, and elapsed time after death can reduce diagnostic yield. If treatment cannot wait, retain pretreatment images, water, fresh tissue, and representative affected fish whenever possible.

Treatment and system control

Build the plan around the confirmed genus, fish species, intended use, salinity, system design, biofilter, substrate, invertebrates, and ability to measure the active treatment concentration. Merck lists copper sulfate and chloroquine as options for external dinoflagellates in nonfood fish.[1] This is not a universal tank recipe: drug tolerance, regulatory status, adsorption, organic load, carbonate chemistry, and co-housed taxa can make the same nominal treatment unsafe or ineffective.

For A. ocellatum, treatment must account for stage susceptibility. The SRAC review states that the free-swimming dinospore is susceptible to drug treatment, whereas the attached trophont and encysted tomont are resistant; repeated or prolonged exposure is therefore needed to interrupt reinfection.[2] Do not declare control after respiratory signs improve or visible dust disappears. Continue microscopy-based monitoring and follow the chosen protocol through the susceptible stages.

Copper-containing treatments require measured free copper, not dosing by tank volume alone. Remove susceptible invertebrates from the treatment decision, and do not expose elasmobranchs as though they were teleosts; the SRAC review describes copper as highly toxic to invertebrates and elasmobranchs as more sensitive than teleosts.[2] Chloroquine likewise requires deliberate case selection and confirmation that fish are not food animals. Verify current jurisdictional and institutional requirements before any treatment or discharge.

Supportive care includes stable oxygenation, species-appropriate temperature and salinity, reduced crowding, removal of dead fish, and prompt correction of environmental stressors. Account for activated carbon, ultraviolet sterilization, ozone, protein skimming, substrate, and flow-through exchange because life-support components may remove a drug, alter exposure, or redistribute infective stages. Do not casually shut down biological filtration in a compromised system.

Monitoring, biosecurity, and prognosis

Recheck representative fish with gill and skin wet mounts during and after control rather than relying only on behavior. Track daily mortality, appetite, respiratory effort, water quality, and treatment measurements. Persistent signs should trigger reassessment of identification, concentration verification, system reservoirs, reinfection between linked tanks, and concurrent gill disease.

For A. ocellatum, infected water can transmit dinospores, and the SRAC review also identifies contaminated equipment and aerosolized droplets as potential routes between systems.[2] Quarantine incoming fish, examine gill, skin, and fin material during quarantine, dedicate equipment, manage splash and aerosol pathways, and prevent transport water from entering established systems.

Prognosis depends on respiratory compromise, parasite burden, delay to diagnosis, host susceptibility, mixed disease, and whether the system permits controlled treatment. Merck characterizes control of Amyloodinium as challenging and its prognosis as guarded.[1] Apply that statement to marine amyloodiniosis, not automatically to every freshwater Piscinoodinium case.

Frequently Asked Questions

Can fish have velvet without visible gold dust? Yes. Merck notes that the small golden spots may not be grossly visible when external dinoflagellates are confined to the gills. Respiratory signs should prompt gill examination even when the skin lacks a classic sheen.[1]

Is freshwater velvet the same infection as marine velvet? No. Merck identifies Piscinoodinium in freshwater fish and Amyloodinium in saltwater fish.[1] A. ocellatum also affects brackish-water fish.[2] Keep diagnosis and evidence scoped to the relevant genus, host, and salinity.

What is the first diagnostic test? Merck lists wet mount as the diagnostic method for external dinoflagellates.[1] The broader fish dermatology workflow includes skin scraping and gill biopsy alongside complete water-quality testing.[3]

Can a negative wet mount rule out velvet disease? Not by itself. Sampling site, parasite burden, prior treatment, tissue handling, and timing can reduce yield. Resample appropriate tissues or add histopathology or targeted molecular testing when suspicion remains high.

When is PCR useful for Amyloodinium? PCR can support selected marine or brackish surveillance and low-burden investigations. Levy and colleagues' assay detected A. ocellatum life stages in seawater and worked with gill tissue, but results still require clinical and sampling context.[5]

Why can signs return after treatment starts? In A. ocellatum, the drug-susceptible dinospore emerges from resistant attached and encysted stages over time. The SRAC review therefore describes repeated or prolonged treatment as necessary to interrupt the cycle.[2]

Should every ornamental-fish system receive copper? No. Confirm the organism and consider fish species, water chemistry, invertebrates, system materials, intended use, and the ability to monitor active copper. The SRAC review warns that copper is highly toxic to invertebrates and that elasmobranchs are more sensitive than teleosts.[2]

References

  1. Petty, Francis-Floyd, and Yanong, Merck Veterinary Manual Professional, 2022 — Parasitic Diseases of Fish (2022)
  2. Francis-Floyd and Floyd, Southern Regional Aquaculture Center, 2011 — Amyloodinium ocellatum, an Important Parasite of Cultured Marine Fish (2011)
  3. Palmeiro and Roberts, Veterinary Clinics of North America: Exotic Animal Practice, 2013 — Clinical Approach to Dermatologic Disease in Exotic Animals (2013)
  4. Sudhagar et al., Pathogens, 2022 — Piscinoodinium Outbreak in Captive-Bred Arulius Barb (2022)
  5. Levy et al., Diseases of Aquatic Organisms, 2007 — Specific PCR Assay for Amyloodinium ocellatum (2007)

More clinical updates